Tempus

Tempus is an image analysis tool. Tempus pairs a large library of clinical and molecular data with an AI-enabled operating system for precision medicine, starting with cancer and extending to neuropsychiatry, cardiology and radiology. It serves providers, life sciences teams, researchers and patients through specialty-specific lab services, data products and trial support.

Tempus is a precision medicine platform built around a large library of clinical and molecular data, paired with an operating system intended to make that data accessible and useful. The company describes its starting point as cancer, with oncology as the deepest area of coverage, and extends into neurology and psychiatry, cardiology and radiology. Its stated posture is data-driven, AI-enabled and human-centered, meaning the software supports clinicians and researchers rather than replacing their judgment. For care teams, Tempus organizes ordering and results around specialties. Providers working in oncology, pathology, neurology and psychiatry, cardiology or radiology get dedicated entry points, and academic and research centers are treated as a separate audience with their own pathway. Patients and patient advocacy groups have their own sections covering oncology, clinical trials and neuropsychiatry, which suggests the product is meant to be used across the clinical encounter rather than by a single role. For life sciences organizations, the offering splits into distinct workstreams: data and AI products, companion diagnostics and lab services, clinical research operations, clinical trial recruitment, and care gap intelligence. In practice this means a pharmaceutical or diagnostics team can work with Tempus at several points in a development program, from trial site and patient identification through to data products built on de-identified clinical and molecular records. Digital pathology is presented as its own solution area, reflecting the imaging-heavy nature of modern cancer diagnostics. Where Tempus sits among alternatives is narrower than a general AI tool directory implies. It is not a creative or generative content product despite being filed here for lack of a closer match. It competes with other precision medicine and real-world data vendors, and its differentiators are breadth of paired clinical and molecular data plus specialty-specific lab services. Access, pricing and contracting are not published on the homepage, so buyers should expect an enterprise or institutional conversation rather than a self-serve signup.